Jump to:
loading...| Preferred Name |
brivaracetam |
| Synonyms |
1-pyrrolidineacetamide, alpha-ethyl-2-oxo-4-propyl-, (alphaS,4R)- |
| ID |
http://purl.bioontology.org/ontology/MESH/C482793 |
| altLabel |
1-pyrrolidineacetamide, alpha-ethyl-2-oxo-4-propyl-, (alphaS,4R)- UCB-34714 Briviact UCB 34714 2-(2-oxo-4-propylpyrrolidin-1-yl)butanamide UCB34714 (2S)-2-((4R)-2-oxo-4-propylpyrrolidin-1-yl)butanamide |
| cui |
C4083381 C1699861 C1436082 |
| HM |
D011760 |
| Inverse of RB |
0 U863JGG2IA |
| isa | |
| LT |
TRD |
| Mapped to | |
| MDA |
20040319 |
| MeSH Frequency |
114 |
| MMR |
20161027 |
| notation |
C482793 |
| PA |
D000927 |
| prefLabel |
brivaracetam |
| SC |
1 |
| Scope Statement |
A pyrrolidinone compound that is used to treat partial onset seizures in adult patients; structure in first source. |
| SRC |
J Med Chem 2004 Jan 29;47(3):530-49 |
| TERMUI |
T578122 T000908842 T578120 T578121 T671415 T000908444 T578123 T000908840 |
| TH |
NLM (2006) NLM (2004) NLM (2017) FDA SRS (2017) USAN (19XX) INN (19XX) |
| tui |
T109 T121 |